Koninklijke Philips (PHG) notified its customers about a possible power malfunction in itsTrilogy Evo continuous ventilators and initiated a software update to resolve the same in March. The FDA classified this action as Class I level recall, the most serious type of recall, as the use of these devices without the software update may cause serious injuries or death. This recall is a correction and not a product removal. It includes all susceptible devices — Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Tr ...